vs
Side-by-side financial comparison of SELECT MEDICAL HOLDINGS CORP (SEM) and Virtu Financial, Inc. (VIRT). Click either name above to swap in a different company.
SELECT MEDICAL HOLDINGS CORP is the larger business by last-quarter revenue ($1.4B vs $1.1B, roughly 1.3× Virtu Financial, Inc.). Virtu Financial, Inc. runs the higher net margin — 31.6% vs 1.4%, a 30.2% gap on every dollar of revenue. On growth, Virtu Financial, Inc. posted the faster year-over-year revenue change (30.7% vs 6.4%). Over the past eight quarters, Virtu Financial, Inc.'s revenue compounded faster (25.7% CAGR vs 2.8%).
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
Virtu Financial, Inc. is an American high-frequency trading company. The company went public on the Nasdaq in 2015.
SEM vs VIRT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $1.1B |
| Net Profit | $20.2M | $346.6M |
| Gross Margin | — | — |
| Operating Margin | 4.6% | 37.4% |
| Net Margin | 1.4% | 31.6% |
| Revenue YoY | 6.4% | 30.7% |
| Net Profit YoY | 225.7% | 82.8% |
| EPS (diluted) | $0.17 | $1.99 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.1B | ||
| Q4 25 | $1.4B | $969.9M | ||
| Q3 25 | $1.4B | $824.8M | ||
| Q2 25 | $1.3B | $999.6M | ||
| Q1 25 | $1.4B | $837.9M | ||
| Q4 24 | $1.3B | $834.3M | ||
| Q3 24 | $1.3B | $706.8M | ||
| Q2 24 | $1.3B | $693.0M |
| Q1 26 | — | $346.6M | ||
| Q4 25 | $20.2M | $139.9M | ||
| Q3 25 | $28.8M | $77.6M | ||
| Q2 25 | $40.6M | $151.2M | ||
| Q1 25 | $56.7M | $99.7M | ||
| Q4 24 | $-16.1M | $94.1M | ||
| Q3 24 | $55.6M | $60.0M | ||
| Q2 24 | $77.6M | $66.6M |
| Q1 26 | — | 37.4% | ||
| Q4 25 | 4.6% | 35.4% | ||
| Q3 25 | 5.4% | 21.8% | ||
| Q2 25 | 6.5% | 34.7% | ||
| Q1 25 | 8.3% | 26.7% | ||
| Q4 24 | 1.6% | 24.3% | ||
| Q3 24 | 4.3% | 20.8% | ||
| Q2 24 | 5.8% | 22.4% |
| Q1 26 | — | 31.6% | ||
| Q4 25 | 1.4% | 14.4% | ||
| Q3 25 | 2.1% | 9.4% | ||
| Q2 25 | 3.0% | 15.1% | ||
| Q1 25 | 4.2% | 11.9% | ||
| Q4 24 | -1.2% | 11.3% | ||
| Q3 24 | 4.4% | 8.5% | ||
| Q2 24 | 6.1% | 9.6% |
| Q1 26 | — | $1.99 | ||
| Q4 25 | $0.17 | $1.54 | ||
| Q3 25 | $0.23 | $0.86 | ||
| Q2 25 | $0.32 | $1.65 | ||
| Q1 25 | $0.44 | $1.08 | ||
| Q4 24 | $-0.12 | $1.03 | ||
| Q3 24 | $0.43 | $0.64 | ||
| Q2 24 | $0.60 | $0.71 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $26.5M | $973.2M |
| Total DebtLower is stronger | $1.8B | — |
| Stockholders' EquityBook value | $1.7B | $2.2B |
| Total Assets | $5.9B | $25.1B |
| Debt / EquityLower = less leverage | 1.06× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $973.2M | ||
| Q4 25 | $26.5M | $1.1B | ||
| Q3 25 | $60.1M | $707.9M | ||
| Q2 25 | $52.3M | $752.1M | ||
| Q1 25 | $53.2M | $723.6M | ||
| Q4 24 | $59.7M | $872.5M | ||
| Q3 24 | $191.5M | $701.4M | ||
| Q2 24 | $111.2M | $684.8M |
| Q1 26 | — | — | ||
| Q4 25 | $1.8B | $2.0B | ||
| Q3 25 | $1.7B | $2.0B | ||
| Q2 25 | $1.8B | $1.7B | ||
| Q1 25 | $1.8B | $1.7B | ||
| Q4 24 | $1.7B | $1.7B | ||
| Q3 24 | $3.1B | $1.7B | ||
| Q2 24 | $3.6B | $1.7B |
| Q1 26 | — | $2.2B | ||
| Q4 25 | $1.7B | $1.6B | ||
| Q3 25 | $1.7B | $1.5B | ||
| Q2 25 | $1.7B | $1.4B | ||
| Q1 25 | $1.7B | $1.3B | ||
| Q4 24 | $1.7B | $1.3B | ||
| Q3 24 | $1.9B | $1.2B | ||
| Q2 24 | $1.4B | $1.2B |
| Q1 26 | — | $25.1B | ||
| Q4 25 | $5.9B | $20.2B | ||
| Q3 25 | $5.7B | $21.3B | ||
| Q2 25 | $5.7B | $19.3B | ||
| Q1 25 | $5.7B | $17.5B | ||
| Q4 24 | $5.6B | $15.4B | ||
| Q3 24 | $8.0B | $14.4B | ||
| Q2 24 | $7.9B | $13.9B |
| Q1 26 | — | — | ||
| Q4 25 | 1.06× | 1.29× | ||
| Q3 25 | 1.03× | 1.40× | ||
| Q2 25 | 1.10× | 1.24× | ||
| Q1 25 | 1.03× | 1.33× | ||
| Q4 24 | 1.01× | 1.39× | ||
| Q3 24 | 1.62× | 1.41× | ||
| Q2 24 | 2.54× | 1.41× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $64.3M | — |
| Free Cash FlowOCF − Capex | $5.2M | — |
| FCF MarginFCF / Revenue | 0.4% | — |
| Capex IntensityCapex / Revenue | 4.2% | — |
| Cash ConversionOCF / Net Profit | 3.19× | — |
| TTM Free Cash FlowTrailing 4 quarters | $117.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $64.3M | $518.4M | ||
| Q3 25 | $175.3M | $-68.7M | ||
| Q2 25 | $110.3M | $62.8M | ||
| Q1 25 | $-3.5M | $15.0M | ||
| Q4 24 | $125.4M | $599.0M | ||
| Q3 24 | $181.0M | $112.1M | ||
| Q2 24 | $278.2M | $490.8M |
| Q1 26 | — | — | ||
| Q4 25 | $5.2M | $495.6M | ||
| Q3 25 | $122.2M | $-76.7M | ||
| Q2 25 | $45.6M | $57.6M | ||
| Q1 25 | $-55.8M | $9.2M | ||
| Q4 24 | $62.0M | $586.6M | ||
| Q3 24 | $130.3M | $106.2M | ||
| Q2 24 | $222.6M | $486.9M |
| Q1 26 | — | — | ||
| Q4 25 | 0.4% | 51.1% | ||
| Q3 25 | 9.0% | -9.3% | ||
| Q2 25 | 3.4% | 5.8% | ||
| Q1 25 | -4.1% | 1.1% | ||
| Q4 24 | 4.7% | 70.3% | ||
| Q3 24 | 10.2% | 15.0% | ||
| Q2 24 | 17.4% | 70.3% |
| Q1 26 | — | — | ||
| Q4 25 | 4.2% | 2.4% | ||
| Q3 25 | 3.9% | 1.0% | ||
| Q2 25 | 4.8% | 0.5% | ||
| Q1 25 | 3.9% | 0.7% | ||
| Q4 24 | 4.8% | 1.5% | ||
| Q3 24 | 4.0% | 0.8% | ||
| Q2 24 | 4.3% | 0.6% |
| Q1 26 | — | — | ||
| Q4 25 | 3.19× | 3.71× | ||
| Q3 25 | 6.09× | -0.89× | ||
| Q2 25 | 2.72× | 0.42× | ||
| Q1 25 | -0.06× | 0.15× | ||
| Q4 24 | — | 6.37× | ||
| Q3 24 | 3.25× | 1.87× | ||
| Q2 24 | 3.59× | 7.37× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
VIRT
| Trading income, net | $789.1M | 72% |
| Commissions, net and technology services | $186.6M | 17% |
| Other | $119.6M | 11% |
